Home › Hereditary Angioedemas
Hereditary Angioedemas clinical trials recruiting in the U.S.
9 studies for Hereditary Angioedemas are recruiting participants at sites across the United States.
Cities with the most studies
- Harrisburg, PA4 studies
- St. Louis, MO4 studies
- Washington, DC4 studies
- Cincinnati, OH3 studies
- San Diego, CA3 studies
- Concord, CA3 studies
By state
- Arizona3 studies
- California5 studies
- Florida4 studies
- Maryland4 studies
- Missouri4 studies
- New York3 studies
- Ohio3 studies
- Pennsylvania4 studies
Recently updated studies
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266805Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)
RecruitingPhase 4
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT07654829STOP-HAE: A Phase 3 Study of ADX-324 in HAE
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06960213Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07428499Donidalorsen Treatment in Children With Hereditary Angioedema
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 2, 2026 · NCT07298447Angioedema Biomarker Research Study
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 75 · All sexes · Updated Aug 24, 2026 · NCT06210698A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
RecruitingObservational study
Ages 12 and older · All sexes · Updated Jun 3, 2026 · NCT07001280Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Feb 27, 2026 · NCT06919003Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Jul 2, 2025 · NCT07046806From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.